Physician profile
John D Hunter
NPI 1780845040
$33,327.17
in general payments reported to CMS, 2019-2025
17 companies · $1,345 in 2025
The $1,345 reported for 2025 was more than what 76% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,730 · 2020: $229 · 2021: $247 · 2022: $19K · 2023: $583 · 2024: $9,544 · 2025: $1,345.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,075 · Education: $2,750 · Food and Beverage: $2,639 · Gift: $8.74.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,074.80 |
| Education | $2,750.00 |
| Food and Beverage | $2,639.20 |
| Gift | $8.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $17,828.30 | 2019-2025 | Da Vinci Surgical System |
| Ambu Innovation Gmbh | $13,691.81 | 2022 | |
| Medtronic, INC. | $443.43 | 2023-2024 | Ligasure, Interstim, Absorbatack |
| Baxter Healthcare | $296.87 | 2021-2024 | Tisseel, Seprafilm |
| Ambu INC. | $276.35 | 2022 | |
| Trevena, INC. | $161.89 | 2021-2023 | Olinvyk |
| Virtual Incision Corporation | $154.00 | 2024 | Mira |
| Axonics, INC. | $120.23 | 2024 | Axonics |
| Myriad Genetic Laboratories, INC. | $118.65 | 2024 | Myrisk |
| Histosonics, INC. | $71.44 | 2025 | |
| Merck Sharp & Dohme LLC | $44.97 | 2019-2022 | |
| Smith+Nephew, INC. | $28.35 | 2025 | Renasys Touch |
| Takeda Pharmaceuticals U.S.A., INC. | $22.12 | 2023 | Gattex |
| Tela Bio, INC. | $18.98 | 2022 | |
| Pacira Pharmaceuticals Incorporated | $18.47 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acell, INC. | $16.00 | 2020 | |
| Ethicon US, LLC | $15.31 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Hunter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.